SCHEMBL6981447

SCHEMBL6981447

O=C(Cc1ccccc1)Nc1ccc2c(c1)CCCN2

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.68
RAB9A P51151 3/20 0.68
MEN1 O00255 6/20 0.52
KMT2A Q03164 6/20 0.52
ALDH1A1 P00352 5/20 0.50
MAPT P10636 4/20 0.50
KDM4E B2RXH2 3/20 0.50
LMNA P02545 3/20 0.50
HPGD P15428 2/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
EPHX2 P34913 1/20 0.50
TMPRSS2 O15393 1/20 0.49
MAPK14 Q16539 1/20 0.49
PLAU P00749 1/20 0.49
USP2 O75604 1/20 0.48
POLB P06746 1/20 0.48
BLM P54132 1/20 0.48
NR4A1 P22736 1/20 0.48
GAA P10253 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30718462 0.92 NPC1 (0.64) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL27370339 0.92 NPC1 (0.64) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL691153 0.81 MAPT (0.60) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL6984836 0.81 RAB9A (0.66) NPC1RAB9AKMT2AALDH1A1MAPT
SCHEMBL5800735 0.80 GAA (0.58) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL6421787 0.80 RAB9A (0.52) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL3545975 0.79 PLAU (0.50) NPC1RAB9AMEN1KMT2AALDH1A1
Hydrochloric Acid SCHEMBL3548106 0.78 PLAU (0.49) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL9179356 0.77 PTPRC (0.55) NPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL5053574 0.77 PLAU (0.56) NPC1RAB9AALDH1A1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed